Efferent neuro-ophthalmic complications of coronavirus disease 2019
Authors:
- 13 September 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Ophthalmology
- Vol. 33 (6) , 471-484
Abstract
Purpose of review: We set out to describe efferent neuro-ophthalmological complications that have been reported in association with coronavirus disease 2019 (COVID-19) infection. We describe syndromes affecting ocular motility and elaborate on mechanisms of disease, including para-infectious inflammation, hypercoagulability, endothelial damage, and direct neurotropic viral invasion. Despite global vaccination programs, COVID-19 continues to pose an international threat that may rarely result in diplopia or nystagmus. Recent findings: Efferent complications include cranial nerve palsies leading to diplopia, either isolated or in association with Miller Fisher syndrome. Nystagmus has been observed in the setting of hemorrhagic acute necrotizing encephalopathy and brainstem infarcts, and opsoclonus syndrome has been described. Summary: Observed neuro-ophthalmic associations need to be confirmed through larger comparative studies. Meanwhile, the range of possible complications should be recognized by neurologists and ophthalmologists alike, to facilitate faster diagnosis and treatment of both COVID-19 and its neuro-ophthalmic manifestations.Keywords
This publication has 111 references indexed in Scilit:
- Saccadic Burst Cell Membrane Dysfunction Is Responsible for Saccadic OscillationsJournal of Neuro-Ophthalmology, 2008
- What clinical disorders tell us about the neural control of saccadic eye movementsBrain, 2006
- Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virusNature, 2006
- Cerebellar activation in opsoclonusNeurology, 2003
- Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisitedBone Marrow Transplantation, 2000
- Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and TaiwanBrain and Development, 1997
- Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.Journal of Clinical Investigation, 1995
- Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndromeAnnals of Neurology, 1992
- Anti‐Ri: An antibody associated with paraneoplastic opsoclonus and breast cancerAnnals of Neurology, 1991
- Opsoclonus and Occult NeuroblastomaNew England Journal of Medicine, 1968